Neurogene Stock Plummets 44%: Is All Hope Lost for This Biotech?"
Neurogene has been on a huge run in 2024. That came to a halt after the company released trial results. But, the results may be better than the market thinks.
3 Growth Stocks That Could Go Parabolic in 2024
These innovation-oriented companies could take flight this year.
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Taysha Gene Therapies, Inc. (NASDAQ: TSHA) for Potential Breaches of Fiduciary Duty By Its Board of Directors
/PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of...
2 Healthcare Stocks That More Than Tripled Recently. Can They Keep Climbing?
These highly volatile stocks recently rocketed higher, but what are the chances that they'll be able to provide further gains?